Researchers have discovered a gene linked to Parkinson's disease may also strengthen the body's ability to fight dangerous infections. The study found that a well-studied mutation in the LRRK2 gene increases the production of reactive oxygen species, making immune cells more effective at eliminating intracellular bacteria.
SourceUniversity of Ottawa·JournalCellular and Molecular Immunology·TypeImaging analysis·DateAug 19, 2026
A nationwide study found that people living within 500 feet of dry cleaners had a 14% greater risk of developing Parkinson's disease compared to those living further away. The study, led by Barrow Neurological Institute, highlights the potential role of environmental exposures in disease development.
SourceDignity Health Arizona·Journalnpj Parkinson s Disease·DateAug 19, 2026
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers have discovered that cells rely on polyamines to store iron in a safe state, preventing destructive reactions. This finding has implications for cancer treatment and may offer new clues about early-onset Parkinson's disease.
SourceWhitehead Institute for Biomedical Research·JournalCell·DateAug 14, 2026
Researchers analyzed EBRAINS-hosted brain data to determine that whole-brain activity patterns predict stimulation outcomes better than local recordings. Targeting specific sensorimotor and visual networks reduces response variability by up to 24%. This study highlights the value of open datasets for enabling large-scale analyses.
Researchers at Weill Cornell Medicine have identified structural changes that enable the LRRK2 protein to become overactive, a key step in Parkinson's disease progression. Understanding these changes is crucial for developing targeted therapies to slow or halt the disease.
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers found that exercise-induced molecular changes contribute to neuronal health, improving movement and quality of life in PD patients. Exercise types such as aerobic exercises, resistance training, balance training, and multimodal exercise were found to be helpful in reducing falls, disabilities, and improving brain function.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateAug 7, 2026
The first complete marmoset genome is now available, providing a high-quality reference for studying complex diseases like Alzheimer's. The new genome reveals variation in genes linked to Alzheimer's disease, as well as immune system genes and previously un-catalogued ribosomal DNA genes.
SourceUniversity of California - Santa Cruz·JournalCell·DateAug 6, 2026
Researchers used real human brain tissue samples to test the underlying mechanisms of deep brain stimulation. They found that brain cells became more synchronized in communicating, similar to memory formation, while altering gene expression across different types of brain cells.
SourceUniversity of California - Los Angeles Health Sciences·JournalNature·TypeExperimental study·DateAug 5, 2026
A new USC study uses AI to generate detailed maps of brain aging, revealing distinct patterns of neurodegeneration in specific regions. The approach sheds light on how local brain age correlates with changes in cognitive function across the lifespan.
SourceUniversity of Southern California·JournalProceedings of the National Academy of Sciences·TypeImaging analysis·DateAug 3, 2026
A soft, wearable fingertip patch continuously monitors levodopa levels in patients' sweat, comparable to standard laboratory blood tests. This technology enables precise customization of daily medication schedules for patients at home, potentially improving treatment outcomes.
SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateJul 27, 2026
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
Researchers identify a specialized lymphatic network in the brain that enables cerebrospinal fluid drainage, which declines with age but can be restored through intranasal VEGF-C delivery. This discovery provides new insights into brain waste clearance and its link to neurodegenerative disorders.
SourceInstitute for Basic Science·JournalCell·TypeExperimental study·DateJul 22, 2026
Researchers found that bee venom can improve motor function and cognitive decline in a mouse model of Parkinson's disease when used alongside conventional therapy. The study suggests promising benefits for developing adjunct therapies to improve treatment outcomes.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeExperimental study·DateJul 22, 2026
Long-term exposure to road traffic noise was associated with a higher risk of Parkinson's disease, according to the study. Having a quiet facade mitigated this association, suggesting that reducing noise levels may be a viable strategy for preventing or managing the condition.
A Bar-Ilan University study finds that patients with chronic illnesses often feel compelled to become experts in their condition due to inadequate healthcare systems. This phenomenon is referred to as 'forced agency,' where patients must acquire and evaluate medical knowledge without formal training, leading to an 'epistemic burden.'
SourceBar-Ilan University·JournalSocial Science & Medicine·DateJul 20, 2026
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
Researchers analyzed genetic data from almost 100,000 people across eleven world regions, identifying regional differences in gene variants GBA1 and LRRK2. This study is crucial for globally equitable diagnostics and therapies as it highlights the need to consider ancestry when diagnosing Parkinson's disease.
SourceUniversity of Lübeck·JournalThe Lancet Neurology·TypeObservational study·DateJul 16, 2026
Researchers at Kyoto University discovered an RNA aptamer, 1R6, that targets the disordered regions of alpha-synuclein protein, inhibiting its aggregation and promoting disassembly of pre-existing aggregates. This finding offers a new therapeutic strategy for neurodegenerative disorders like Parkinson's disease.
SourceKyoto University·JournalNature Communications·TypeExperimental study·DateJul 16, 2026
Researchers have developed a new drug candidate, SB-0110, that boosts L-dopa's benefits while reducing dyskinetic side effects in animal models of Parkinson’s disease. The compound preserves the gene-activity patterns tied to L-dopa’s benefits while counteracting biological changes associated with dyskinesia.
SourceUniversity of California - San Diego·JournalScience Translational Medicine·TypeExperimental study·DateJul 15, 2026
A University of Houston chemist is uncovering how copper imbalances in neurons contribute to neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS. The new imaging technique provides a closer look at individual protein behaviors inside living cells, giving researchers insight into the cellular pathways that fail.
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
This study found that SNCA genetic variants are associated with MSA, and specific α-synuclein transcript levels are altered in MSA patients. The results suggest the importance of analyzing different SNCA transcript variants for biomarker research and understanding MSA pathology.
SourceXia & He Publishing Inc.·JournalGene Expression·DateJul 13, 2026
A landmark study has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible and safe. Eight patients received the transplanted cell product, with no serious side effects observed during the first year of follow-up.
SourceLund University·JournalNature Medicine·DateJul 9, 2026
A systematic review and meta-analysis found two air pollutants associated with an increased risk of Parkinson's disease. The study suggests that long-term exposure to fine particulate matter (PM2.5) may interact with genetic susceptibility, leading to oxidative stress and neuroinflammation.
SourceUniversity of Cambridge·JournalEnvironment International·TypeSystematic review·DateJul 8, 2026
Research found that Parkinson's disease triggers shared 'stress responses' but also differs between men and women at the cellular level, particularly in how glial cells manage energy and protect nerve connections. This discovery may lead to more personalized treatments for patients.
SourceFederation of European Neuroscience Societies·TypeObservational study·DateJul 7, 2026
Researchers have identified a promising drug to treat neurodegenerative conditions, including Alzheimer's disease and traumatic brain injury. The study found that inhibition of an enzyme called 15-PGDH was potently neuroprotective by restraining the production of reactive oxygen species that damage the brain.
SourceUniversity Hospitals Cleveland Medical Center·JournalRedox Biology·DateJul 6, 2026
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
A new study reveals IL-6 plays a crucial role in regulating neuroinflammation and protecting the nigrostriatal pathway in Parkinson's disease. The research found that restoring IL-6 levels can reverse aggravated pathology and partially ameliorate motor dysfunction in mice.
SourceCompuscript Ltd·JournalGenes & Diseases·DateJul 6, 2026
Researchers propose a theoretical framework linking rubidium ion metabolic dysregulation to Parkinson's disease, highlighting the role of ionic homeostasis imbalance in neurodegeneration. Rubidium may serve as a potential biomarker and therapeutic target for early intervention.
SourceChina Association of Chinese Medicine, eTM·JournalWorld Journal of Integrated Traditional and Western Medicine·TypeData/statistical analysis·DateJul 3, 2026
Researchers found that patients with Parkinson's disease showing little to no Lewy bodies despite long-standing, clinically advanced disease. The study provides new insight into the relationship between clinical symptoms and neuropathological progression.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·Journalnpj Parkinson s Disease·TypeObservational study·DateJul 1, 2026
A new study by Texas A&M University researchers uses a non-toxic virus to induce Parkinson's-like brain damage and movement problems in animal models. The breakthrough model confirms that viral infections can trigger Parkinson's disease, paving the way for future studies on early warning signs and biological markers.
SourceTexas A&M University·JournalBrain Behavior & Immunity - Health·TypeExperimental study·DateJun 29, 2026
Research presented at the European Academy of Neurology Congress 2026 found that women with Parkinson's disease had significantly greater amyloid plaque burden and neuritic plaque density compared to men. The study suggests that women may be more susceptible to Alzheimer's-related changes in the brain.
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Salk Institute researchers discovered chronoferroptosis, a chronic stress pathway in cells that causes neurons to become less resilient over time and more susceptible to neurodegeneration. Iron accumulation was found to lower the cells' defenses, making them more vulnerable to stressors.
SourceSalk Institute·JournalCell Death Discovery·DateJun 25, 2026
Researchers study blind Mexican cavefish to understand how evolution rewires the brain and shapes behavior. They found that cavefish become more active in light, a response believed to help them avoid predators.
SourceFlorida Atlantic University·JournalScience Advances·TypeExperimental study·DateJun 24, 2026
A new research project will study the effect of immune cell aging on Parkinson's disease risk and progression. The team aims to identify individuals at greater risk for Parkinson's disease and develop targeted treatments.
Researchers developed a new approach to deep brain stimulation that adapts to real-time patient activity, improving walking and mobility. This therapy adjusts stimulation dynamically based on the patient's ongoing locomotor activity, helping patients move more naturally.
SourceEcole Polytechnique Fédérale de Lausanne·JournalNature Medicine·DateJun 15, 2026
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Researchers created a personalized adaptive DBS system that detects neural signals associated with each step and adjusts stimulation in real time, improving gait symmetry and reducing falls. The study demonstrates the potential for brain stimulation to adapt to behavior itself, opening doors to future therapies.
SourceUniversity of California - San Francisco·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJun 15, 2026
Research finds different underlying factors driving growth in people living with Parkinson's disease, multiple sclerosis, and motor neuron disease. Improvements in treatment and care contribute to increased life expectancy for MS and MND patients.
Researchers found that pramipexole, a Parkinson's disease medication, improved symptoms of anhedonia in patients with treatment-resistant depression. The therapy was associated with positive effects on the brain's reward system and increased physical activity.
SourceLund University·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJun 12, 2026
A new anti-inflammatory molecule has shown promising results in protecting neurons and delaying disease progression in mice with Parkinson's disease. The study, published in Neuropharmacology, found that the Ac2-26 peptide mitigated neuroinflammation and protected against cell death.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalNeuropharmacology·DateJun 12, 2026
A study analyzing French and Swedish national health databases reveals a rise in Parkinson's disease, multiple sclerosis, and motor neuron diseases' prevalence worldwide. Improved life expectancy and therapies contribute to the increase in multiple sclerosis cases, while population aging is the primary driver of ALS rising incidence.
SourceInstitut du Cerveau (Paris Brain Institute)·JournalNeurology·TypeData/statistical analysis·DateJun 8, 2026
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
A medical school team has been awarded a $6 million grant to develop gene-replacement preclinical models of Parkinson's disease. The goal is to better understand the disease and support early-stage therapeutic research by identifying critical pathogenic mechanisms.
SourceUniversity of Minnesota Medical School·DateMay 21, 2026
A three-year research project aims to identify the molecular pathways linking exposure to pesticides and air pollution to Parkinson's disease development and progression. The study will analyze human stem cells, animal models, and genetic analyses to understand how environmental toxins trigger disease onset.
SourceUniversity of California - Los Angeles Health Sciences·DateMay 14, 2026
A case-control study found associations between ambient particulate matter and nitrogen dioxide exposure and increased risks of Lewy body dementia and Parkinson disease-related dementia. The study's findings suggest air pollution may impact brain health, warranting concern.
SourceJAMA Network·JournalJAMA Network Open·DateMay 14, 2026
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
A team of international researchers will investigate the underlying biology of psychiatric and cognitive symptoms in Parkinson's disease, with a focus on depression, anxiety, and other non-motor symptoms. The study aims to improve diagnosis and treatment of these symptoms, which are common but poorly understood in the disease.
The Pittsburgh Institute for Neurodegenerative Diseases will investigate how environmental exposures cause neurodegeneration and develop methods to prevent or mitigate these exposures. The project aims to improve diagnostics and future therapies for Parkinson's disease, a condition characterized by heterogeneity across individuals.
A Rutgers research team identified a key mechanism linking the brain and body, which could help diagnose and treat neurological conditions like Parkinson's disease and alcohol use disorder. The discovery found that the anterior cingulate cortex controls autonomic responses, including heart rate and pupil dilation.
SourceRutgers University·JournalScience Advances·DateMay 8, 2026
Researchers developed a new photonic material using lead iodide, enabling high-speed data transmission in the terahertz frequency range. The material confines light within submicrometer regions, paving the way for integrated photonic circuits that could replace or complement electronic circuits.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalNature Communications·DateMay 4, 2026
Scientists have discovered a protective brain pathway that preserves dopamine-producing neurons and reduces degeneration in female models with Parkinson's disease. The study suggests that strengthening this pathway could help slow the progression of the disease, offering new potential for treatment.
SourceTexas A&M University·JournalJNeurosci·DateMay 4, 2026
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
A new review proposes a prevention-focused framework for understanding Parkinson's disease risk, highlighting the role of early-life vulnerability, environmental exposures, and resilience factors. The study suggests that susceptibility to PD may begin earlier in life through interactions between biology and environment.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateApr 28, 2026
A global research network, led by ASAP and MJFF, is expanding its efforts to map the biological blueprint of Parkinson's disease and develop a standardized toolkit of global research resources. This expansion aims to accelerate the development of personalized therapies by understanding the disease's inherent heterogeneity.
A study using mice and simulations found that abdominal contractions compress blood vessels connected to the spinal cord and brain, enabling gentle brain movement that facilitates cerebrospinal fluid flow and potentially removes neural waste. This mechanism may explain why exercise is thought to benefit brain health.
SourcePenn State·JournalNature Neuroscience·DateApr 27, 2026
Researchers discovered that small lesions in white matter can trigger a response in connected grey matter, leading to neuronal activity fall, microglia activation, and synapse loss. However, this response is part of the repair process, essential for brain regeneration.
SourceCambridge Stem Cell Institute·JournalNature·DateApr 22, 2026
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
A new study found that people with Parkinson's disease and those in its prodromal stage often report 'brain fog' despite normal objective cognitive scores. The researchers suggest targeting anxiety and depression may help improve quality of life.
SourceBoston University·JournalNeuropsychology·TypeObservational study·DateApr 21, 2026
A recent study from the University of Eastern Finland found that people with Parkinson's disease are using psychotropics more frequently than controls, even before diagnosis. The use of psychotropic medications increases as the disease progresses, reflecting emerging non-motor symptoms and worsening disease progression.
SourceUniversity of Eastern Finland·JournalBritish Journal of Clinical Pharmacology·DateApr 21, 2026
Dr. Glenda Halliday has been awarded the 2026 Jay Van Andel Award for her pioneering work on Parkinson's and related neurodegenerative disorders, advancing understanding of clinical symptoms and underlying brain changes.
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
A new study reveals that people with Parkinson's disease have a distinct gut microbiome, as do those at genetic risk but without symptoms. This could lead to early detection and potential prevention strategies.
SourceUniversity College London·JournalNature Medicine·TypeObservational study·DateApr 20, 2026
Researchers developed a nasal spray that reversibly reduces brain inflammation, restores cellular power plants, and improves memory. The treatment bypasses the brain's protective shield through intranasal delivery, suppressing chronic inflammation and promoting successful brain aging.
SourceTexas A&M University·JournalJournal of Extracellular Vesicles·DateApr 14, 2026
The Barrow Neuro Analytics Center has nearly doubled its dedicated research space to 18,000 square feet, supporting growing neurological research programs. Researchers at the center are globally renowned for their work on Parkinson's disease, Alzheimer's, and other neurological disorders using data-focused methods.
Scientists at NTU Singapore found that glycerol-3-phosphate acyltransferase (GPAT) amplifies α-synuclein toxicity by altering fat metabolism in brain cells. Targeting GPAT activity may offer a new strategy for treating Parkinson's disease.
SourceNanyang Technological University·JournalNature Communications·DateApr 8, 2026
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Researchers propose tailored approaches using CAR platforms, incorporating effector cells like macrophages and Tregs to modulate key processes in neurodegeneration. High-precision immunomodulation is essential for overcoming the complex nature of these diseases.
SourceUniversitat Autonoma de Barcelona·JournalTrends in Pharmacological Sciences·TypeLiterature review·DateApr 8, 2026
The review highlights LRRK2's diverse cellular functions and pathogenic mechanisms in various diseases, including Parkinson's disease and inflammatory disorders. Therapeutic strategies targeting LRRK2, such as kinase inhibitors and emerging approaches like PROTACs and gene therapy, show promise for correcting cellular imbalances and re...
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateApr 1, 2026
Researchers developed an AI model that can detect several neurodegenerative diseases, including Alzheimer's and Parkinson's, from a single blood sample. The model uses protein measurements from over 17,000 patients and outperforms previous models.
SourceLund University·JournalNature Medicine·TypeData/statistical analysis·DateMar 31, 2026
Older adults with and without Parkinson's disease have increased brain activity and muscle signals when recovering from balance disturbances. This makes it more difficult for them to recover their balance.
SourceSociety for Neuroscience·JournaleNeuro·DateMar 23, 2026